Zacks Investment Management Novo Cure LTD Transaction History

Zacks Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $707,427 - $1.08 Million	-5,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $1.02 Million - $1.59 Million	-9,134 Reduced 61.57%	5,700 $986,000
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $400,486 - $767,927	-6,899 Reduced 31.74%	14,834 $1.65 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $666,151 - $866,578	11,646 Added 115.46%	21,733 $1.29 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $151,924 - $254,982	2,663 Added 35.87%	10,087 $679,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $459,248 - $726,067	7,424 New	7,424 $555,000

291

75.7M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.87B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.